Evidence map›Paper›PMID 40005339›Full record

ReviewMedicina (Kaunas, Lithuania)2025

Novel Insight of N6-Methyladenosine in Cardiovascular System.

Huan Zhang, Wei Lu, Haoyue Tang, Aiqun Chen, Xiaofei Gao, Congfei Zhu, Junjie Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. NBiomolecules · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huan ZhangDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Wei LuDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Haoyue TangDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Aiqun ChenDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID 0000-0002-0933-7406
Xiaofei GaoDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID 0000-0001-7428-119X
Congfei ZhuDepartment of Cardiology, Lianshui County People's Hospital, Affiliated Hospital of Kangda College, Nanjing Medical University, Huaian 223400, China.
Junjie ZhangDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.

Funding

Jiangsu Natural Science Foundation BK20221173Jiangsu Provincial Medical Innovation Center CXZX202215Nanjing Health Committee JQX22007, and ZKX23030National Natural Science Foundation of China NSFC 81970307, NSFC 82100357, NSFC 82200385 and NSFC 82270344
6 · The paper itself

Abstract

N6-methyladenosine (m6A) is the most common and abundant internal co-transcriptional modification in eukaryotic RNAs. This modification is catalyzed by m6A methyltransferases, known as "writers", including

Indexed as

AdenosineCardiovascular DiseasesCardiovascular SystemHumansMethylationMethyltransferasesRNA-Binding ProteinsAdenosineMethyltransferasesN-methyladenosineRNA-Binding Proteinsatherosclerosiscardiovascular systemheart failureischemia–hypoxia injuryN6-methyladenosine

Identifiers

PMID40005339
PMCPMC11857502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.